F4303

Fiduxosin hydrochloride

>98% (HPLC), solid

• Synonym(s): (3-[4-((3aR,9bR)-cis-9-methoxy-1,2,3,3a,4,9b-hexahydro-[1]-benzopyrano[3,4-c]Pyrrol-2-yl)butyl]-8-phenyl-pyrazino-[2′,3′:4,5]thieno [3,2-d]pyrimidine-2,4(1H,3H)-dione) hydrochloride
• Empirical Formula (Hill Notation): C₃₀H₂₉N₅O₄S · HCl
• CAS Number: 208992-74-9
• Molecular Weight: 592.11
• MDL number: MFCD04974494
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278788

Properties

• Assay: >98% (HPLC)
• form: solid
• color: white
• solubility: DMSO: soluble 10 mg/mL; H₂O: insoluble
• SMILES string: Cl[H].[H][C@@]12COc3cccc(OC)c3[C@]1([H])CN(CCCCN4C(=O)Nc5c(sc6ncc(nc56)-c7ccccc7)C4=O)C2
• InChI: 1S/C30H29N5O4S.ClH/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18;/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37);1H/t19-,20-;/m1./s1
• InChI key: OFPMGRPQOZABPO-GZJHNZOKSA-N
• Gene Information: human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

Description

Biochem/physiol Actions

α₁-Adrenoceptor antagonist.

Features and Benefits

This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H315,H319,H335
• Precautionary Statements: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Target Organs: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves